Levocetirizine is a second-generation antihistamine formulated as a pill. It contains Levocetirizine Dihydrochloride as its active component. In Hong Kong, Levocetirizine is classified as a prescription-only medication and is regulated by the Hong Kong Department of Health. It is available in 5 mg and 10 mg tablet strengths.
The drug is used primarily to relieve symptoms caused by allergic reactions, such as sneezing, itching, watery eyes, and runny nose. Its pharmacologic profile makes it suitable for day-time use because it is less likely to cause drowsiness compared with first-generation antihistamines.
Levocetirizine belongs to the H1-receptor antagonist class. After oral ingestion, it is absorbed quickly and reaches peak plasma concentrations within 1 hour. The medication blocks histamine from binding to H1 receptors on mast cells, blood vessels, and nerve endings. By preventing this interaction, Levocetirizine reduces the vascular permeability, edema, and sensory nerve activation that produce typical allergy symptoms.
Key pharmacokinetic points:
Levocetirizine is approved by the Hong Kong Department of Health for the following adult indications:
These uses are based on clinical trials demonstrating the drug’s ability to lessen nasal congestion, itching, and wheal-and-flare reactions. Levocetirizine is not indicated for acute asthma attacks or as a primary treatment for eczema.
These effects are generally self-limiting and do not require medical intervention unless they persist.
The drug carries no black-box warning in Hong Kong labeling.
No major cytochrome-P450 interactions have been documented for Levocetirizine.
If you are taking other prescription or over-the-counter products, inform your healthcare provider before starting Levocetirizine.
Standard adult dosing:
5 mg tablet once daily for most allergic conditions.
10 mg tablet may be prescribed for severe chronic urticaria when lower doses are insufficient.
Administration: Swallow the tablet whole with a glass of water. No need to chew or crush.
Missed dose: Take the missed tablet as soon as you remember, unless it is near the time for the next scheduled dose. Do not double the dose.
Renal adjustment: For patients with moderate renal impairment (creatinine clearance 10-50 mL/min), a reduced dose of 5 mg once daily is recommended.
Overdose: Symptoms may include intense drowsiness, dry mouth, and nausea. Seek emergency medical assistance; there is no specific antidote, and treatment is supportive.
Discontinuation: Levocetirizine does not require tapering. Stopping abruptly does not produce withdrawal symptoms.
Routine laboratory monitoring is not required for most adults taking Levocetirizine. However, patients with known renal impairment should have periodic assessment of kidney function. If allergy symptoms persist despite therapy, or if you experience any serious adverse reaction, contact your healthcare provider promptly.
This article provides educational information about Levocetirizine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. The tablet’s absorption is not significantly affected by food, so it can be taken with or without a meal.
Levocetirine does not treat asthma attacks. It may be used for concurrent allergic rhinitis, but individuals with asthma should continue their prescribed inhaled therapy and discuss any additional antihistamine use with their clinician.
Levocetirine is the active enantiomer of cetirizine, offering similar efficacy with a lower incidence of drowsiness in many patients.
Levocetirine is not a prohibited substance under most sporting anti-doping regulations, but athletes should verify current lists and disclose any medication use to their governing body.
Take the missed tablet as soon as you remember, provided it is not within 12 hours of the next scheduled dose. Otherwise, skip the missed dose and continue with the regular dosing schedule.
Keep the medication in its original container, protected from extreme heat or cold, and place it in your carry-on bag to avoid temperature fluctuations in checked luggage.
Dose changes should be guided by a healthcare professional, as the appropriate strength depends on the severity of symptoms and individual health factors.
Combining two antihistamines can increase the risk of sedation and anticholinergic effects; it is advisable to avoid simultaneous use without medical advice.
In Hong Kong, Levocetirine is marketed primarily as a tablet. Alternative formulations, if needed, should be discussed with a pharmacist or physician.
Most adults notice an improvement in nasal congestion, itching, or hives within 30 minutes to one hour after taking the first tablet.
